HomeCompareMDT vs RS

MDT vs RS: Dividend Comparison 2026

MDT yields 3.31% · RS yields 1.61%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RS wins by $5.88M in total portfolio value· pulled ahead in Year 3
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
RS
RS
● Live price
1.61%
Share price
$300.49
Annual div
$4.85
5Y div CAGR
90%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.93M
Annual income
$4,946,851.97
Full RS calculator →

Portfolio growth — MDT vs RS

📍 RS pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTRS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + RS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
RS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
RS
Annual income on $10K today (after 15% tax)
$137.19/yr
After 10yr DRIP, annual income (after tax)
$4,204,824.17/yr
At 15% tax rate, RS beats the other by $4,196,503.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + RS for your $10,000?

MDT: 50%RS: 50%
100% RS50/50100% MDT
Portfolio after 10yr
$2.99M
Annual income
$2,478,320.56/yr
Blended yield
82.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MDT right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
RS
Analyst Ratings
9
Buy
16
Hold
2
Sell
Consensus: Hold
Price Target
$330.00
+9.8% upside vs current
Range: $320.00 — $340.00
Altman Z
6.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
RS buys
0
No recent congressional trades found for MDT or RS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTRS
Forward yield3.31%1.61%
Annual dividend / share$2.84$4.85
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%90%
Portfolio after 10y$54.3K$5.93M
Annual income after 10y$9,789.15$4,946,851.97
Total dividends collected$29.9K$5.83M
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyHold
Analyst price target$111.45$330.00

Year-by-year: MDT vs RS ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrRS PortfolioRS Income/yrGap
1$11,128$428.29$11,007$306.67+$121.00MDT
2$12,483$575.94$12,376$599.36+$107.00MDT
3← crossover$14,138$780.71$14,440$1,196.75$302.00RS
4$16,196$1,068.46$17,930$2,479.30$1.7KRS
5$18,809$1,479.09$24,651$5,466.60$5.8KRS
6$22,201$2,075.70$39,723$13,346.12$17.5KRS
7$26,716$2,960.69$80,692$38,188.01$54.0KRS
8$32,891$4,305.30$224,087$137,747.25$191.2KRS
9$41,599$6,405.16$919,042$679,268.17$877.4KRS
10$54,300$9,789.15$5,930,227$4,946,851.97$5.88MRS

MDT vs RS: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

RSMaterials

Reliance Steel & Aluminum Co. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It also distributes non-ferrous metals products and tubular building products; and manufactures specialty extruded metals, fabricated parts, and welded components. As of December 31, 2021, the company operated a network of approximately 315 locations in 40 states in the United States and 13 in other countries. It sells its products directly to original equipment manufacturers, which primarily include small machine shops and fabricators. The company was founded in 1939 and is headquartered in Los Angeles, California.

Full RS Calculator →
📬

Get this MDT vs RS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.